| dbo:abstract |
Gusperimus is an immunosuppressive drug. It is a derivative of the naturally occurring HSP70 inhibitor spergualin, and inhibits the interleukin-2-stimulated maturation of T cells to the S and G2/M phases and the polarization of the T cells into IFN-gamma-secreting Th1 effector T cells, resulting in the inhibition of growth of activated naive CD4 T cells. Gusperimus was developed by Bristol-Myers Squibb. Currently, it is manufactured and sponsored for use as an orphan drug and for clinical studies by the Japanese company Euro Nippon Kayaku. The patent claim (see quotation) is that Gusperimus may be useful for a variety of hyperreactive inflammatory diseases such as autoimmune diseases. The drug is available in vials containing 100 mg each. There is little information about the pharmacokinetic properties of gusperimus. (en) |
| dbo:alternativeName |
N-[2-[4-(3-Aminopropylamino)butylamino]-1-hydroxy-2-oxoethyl]-7-(diaminomethylideneamino)heptanamide (en) |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Gusperimus.svg?width=300 |
| dbo:wikiPageExternalLink |
http://ec.europa.eu/enterprise/pharmaceuticals/register/o034.htm http://www.ingentaconnect.com/content/adis/rea/2005/00000001/00001080/art00040 https://web.archive.org/web/20060109201017/http:/www.als.net/research/treatments/treatmentDetail.asp%3FtreatmentID=858 https://web.archive.org/web/20120204123305/http:/www.bizbozos.com/nci_Gusperimus |
| dbo:wikiPageID |
6249798 (xsd:integer) |
| dbo:wikiPageLength |
7954 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
993155942 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Amidine dbr:HSP70 dbr:Rheumatoid_arthritis dbr:Vasculitis dbr:Leukopenia dbc:Guanidines dbr:Collins_reagent dbr:Crohn's_disease dbr:Orphan_drug dbr:Ciclosporin dbr:Graft-versus-host_disease dbr:Multiple_sclerosis dbr:NSAID dbr:Bristol-Myers_Squibb dbr:Acetyl_hexapeptide-3 dbr:Amyotrophic_lateral_sclerosis dbc:Immunosuppressants dbc:Orphan_drugs dbr:Dysgeusia dbr:European_Commission dbr:Nippon_Kayaku dbr:Granulomatosis_with_polyangiitis dbr:Transplant_rejection dbr:Guanidine dbr:Tacrolimus dbr:Dibutylhexamethylenediamine dbr:Bone_marrow dbr:Spermidine dbr:Pharmacokinetic dbr:Immunosuppressive_drug dbr:Lupus_erythematosus dbr:Ylide dbr:Aminals dbr:Catalytic_hydrogenation dbr:Carbinolamine dbr:Lithium_hexamethyldisilazane dbr:[4-[(3-Aminopropyl)amino]-butyl]carbamoyl]hydroxymethyl dbr:File:Gusperimus_synthesis.png dbr:Glyoxilamide |
| dbp:imagefile |
Gusperimus.svg (en) |
| dbp:imagename |
Skeletal formula of a gusperimus minor tautomer (en) |
| dbp:othernames |
N-[2-[4-butylamino]-1-hydroxy-2-oxoethyl]-7-heptanamide (en) |
| dbp:verifiedfields |
changed (en) |
| dbp:verifiedrevid |
480476938 (xsd:integer) |
| dbp:watchedfields |
changed (en) |
| dbp:wikiPageUsesTemplate |
dbt:Quantify dbt:Chembox dbt:Chembox_Identifiers dbt:Chembox_Properties dbt:Cite_journal dbt:More_footnotes dbt:Reflist dbt:Cascite dbt:Chembox_Pharmacology dbt:Chembox_Related dbt:Chemboximage dbt:Chemspidercite dbt:Ebicite dbt:Fdacite dbt:Keggcite dbt:Stdinchicite dbt:Immunosuppressants |
| dcterms:subject |
dbc:Guanidines dbc:Immunosuppressants dbc:Orphan_drugs |
| gold:hypernym |
dbr:Drug |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q11173 yago:WikicatOrphanDrugs yago:Agent114778436 yago:CausalAgent100007347 yago:Drug103247620 yago:Immunosuppressant103562958 yago:Matter100020827 yago:Medicine103740161 yago:PhysicalEntity100001930 yago:WikicatImmunosuppressants dbo:ChemicalCompound dbo:Drug yago:Substance100020090 umbel-rc:DrugProduct |
| rdfs:comment |
Gusperimus is an immunosuppressive drug. It is a derivative of the naturally occurring HSP70 inhibitor spergualin, and inhibits the interleukin-2-stimulated maturation of T cells to the S and G2/M phases and the polarization of the T cells into IFN-gamma-secreting Th1 effector T cells, resulting in the inhibition of growth of activated naive CD4 T cells. There is little information about the pharmacokinetic properties of gusperimus. (en) |
| rdfs:label |
Gusperimus (en) |
| owl:sameAs |
freebase:Gusperimus yago-res:Gusperimus wikidata:Gusperimus http://azb.dbpedia.org/resource/قوسپریوموس dbpedia-fa:Gusperimus dbpedia-sh:Gusperimus dbpedia-sr:Gusperimus dbpedia-vi:Gusperimus https://global.dbpedia.org/id/AAAW |
| prov:wasDerivedFrom |
wikipedia-en:Gusperimus?oldid=993155942&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Gusperimus.svg wiki-commons:Special:FilePath/Gusperimus_synthesis.png |
| foaf:isPrimaryTopicOf |
wikipedia-en:Gusperimus |
| is dbo:wikiPageRedirects of |
dbr:ATC_code_L04AA19 dbr:ATCvet_code_QL04AA19 dbr:15-deoxyspergualin |
| is dbo:wikiPageWikiLink of |
dbr:Leupeptin dbr:Acetyl_hexapeptide-3 dbr:ATC_code_L04AA19 dbr:ATCvet_code_QL04AA19 dbr:ATC_code_L04 dbr:Dibutylhexamethylenediamine dbr:List_of_drugs:_G dbr:15-deoxyspergualin |
| is foaf:primaryTopic of |
wikipedia-en:Gusperimus |
